Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Acer Therapeutics stock
Learn how to easily invest in Acer Therapeutics stock.
Acer Therapeutics is a biotechnology business based in the US. Acer Therapeutics shares (ACER) are listed on the NASDAQ and all prices are listed in US Dollars. Acer Therapeutics employs 41 staff and has a trailing 12-month revenue of around $360,000.
How to buy Acer Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACER. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Acer Therapeutics stock price (NASDAQ: ACER)Use our graph to track the performance of ACER stocks over time.
Acer Therapeutics shares at a glance
|Latest market close||$2.22|
|52-week range||$1.11 - $4.56|
|50-day moving average||$2.46|
|200-day moving average||$1.79|
|Wall St. target price||$8.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.39|
Buy Acer Therapeutics stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Acer Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acer Therapeutics price performance over time
|1 week (2023-02-02)||2.30%|
|1 month (2023-01-09)||-19.86%|
|3 months (2022-11-09)||85.00%|
|6 months (2022-08-09)||46.05%|
|1 year (2022-02-09)||-5.13%|
|2 years (2021-02-09)||-42.64%|
|3 years (2020-02-07)||4.53|
|5 years (2018-02-09)||18|
Acer Therapeutics financials
|Gross profit TTM||$1.3 million|
|Return on assets TTM||-62.07%|
|Return on equity TTM||-472.99%|
|Market capitalisation||$43.7 million|
TTM: trailing 12 months
Acer Therapeutics share dividends
We're not expecting Acer Therapeutics to pay a dividend over the next 12 months.
Have Acer Therapeutics's shares ever split?
Acer Therapeutics's shares were split on a 96:1000 basis on 20 September 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 96 shares. This wouldn't directly have changed the overall worth of your Acer Therapeutics shares – just the quantity. However, indirectly, the new 941.7% higher share price could have impacted the market appetite for Acer Therapeutics shares which in turn could have impacted Acer Therapeutics's share price.
Acer Therapeutics share price volatility
Over the last 12 months, Acer Therapeutics's shares have ranged in value from as little as $1.109 up to $4.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acer Therapeutics's is 0.6802. This would suggest that Acer Therapeutics's shares are less volatile than average (for this exchange).
Acer Therapeutics overview
Acer Therapeutics Inc. , a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. .
Acer Therapeutics in the news
Acer Therapeutics Inc. (ACER) Stock Sinks As Market Gains: What You Should Know
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
7 Micro-Cap Stocks to Buy for Risk-Taking Investors
Frequently asked questionsWhat percentage of Acer Therapeutics is owned by insiders or institutions?
Currently 18.386% of Acer Therapeutics shares are held by insiders and 26.102% by institutions. How many people work for Acer Therapeutics?
Latest data suggests 41 work at Acer Therapeutics. When does the fiscal year end for Acer Therapeutics?
Acer Therapeutics's fiscal year ends in December. Where is Acer Therapeutics based?
Acer Therapeutics's address is: One Gateway Center, Newton, MA, United States, 02458
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert